| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
39,300,000 |
| Market
Cap: |
31.83(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.6706 - $3.32 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CohBar is a clinical stage biotechnology company utilizing the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options. In addition, Co. has multiple preclinical programs, such as a program in acute respiratory distress syndrome as well as earlier stage discovery programs. Co.'s pipelines include: CB5138-3, which is for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases; CB4211, which is for the treatment of nonalcoholic steatohepatitis and obesity; and CB5064 Analogs, family of peptides that are agonists of the apelin receptor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2019-11-18 |
4 |
OE |
$0.26 |
$1,300 |
D/D |
5,000 |
15,000 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-11-15 |
4 |
AS |
$1.92 |
$19,201 |
D/D |
(10,000) |
10,000 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-11-15 |
4 |
OE |
$0.73 |
$7,300 |
D/D |
10,000 |
20,000 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2019-11-11 |
4 |
AS |
$1.95 |
$9,750 |
D/D |
(5,000) |
10,000 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2019-11-11 |
4 |
OE |
$0.26 |
$1,300 |
D/D |
5,000 |
15,000 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2019-11-04 |
4 |
AS |
$2.25 |
$11,250 |
D/D |
(5,000) |
10,000 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2019-11-04 |
4 |
OE |
$0.26 |
$1,300 |
D/D |
5,000 |
15,000 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2019-10-31 |
4 |
AS |
$1.95 |
$9,750 |
D/D |
(5,000) |
10,000 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2019-10-31 |
4 |
OE |
$0.26 |
$1,300 |
D/D |
5,000 |
15,000 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-10-30 |
4 |
AS |
$1.90 |
$17,281 |
D/D |
(9,095) |
10,000 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-10-30 |
4 |
OE |
$1.90 |
$17,281 |
D/D |
9,095 |
19,095 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-10-29 |
4 |
AS |
$1.90 |
$1,524 |
D/D |
(802) |
10,000 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-10-29 |
4 |
OE |
$1.90 |
$1,524 |
D/D |
802 |
10,802 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-10-28 |
4 |
AS |
$1.90 |
$196 |
D/D |
(103) |
10,000 |
|
- |
|
| Cundy Kenneth C |
Chief Scientific Officer |
• – – |
2019-10-28 |
4 |
OE |
$1.90 |
$196 |
D/D |
103 |
10,103 |
|
- |
|
| Petkevich Misha |
Director |
– • – |
2019-10-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,691 |
|
- |
|
| Fitzgerald Albion |
Director |
– • – |
2018-06-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
1,929,667 |
|
- |
|
| Stern Jon Leland |
Chief Operating Officer |
• • – |
2018-04-13 |
4 |
OE |
$0.50 |
$3,491 |
D/D |
6,982 |
589,982 |
|
- |
|
| Fitzgerald Albion |
Director |
– • – |
2018-04-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
1,931,667 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2018-02-02 |
4 |
OE |
$2.25 |
$9,000 |
D/D |
4,000 |
10,000 |
|
- |
|
| Goldberg Marc E. |
Director |
– • – |
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
16,667 |
16,667 |
|
- |
|
| Stern Jon Leland |
Chief Operating Officer |
• • – |
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
583,000 |
|
- |
|
| Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
• – – |
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
6,000 |
|
- |
|
| Fitzgerald Albion |
Director |
– • – |
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
166,667 |
1,934,667 |
|
- |
|
| Barzilai Nir Yacov |
Director |
– • • |
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
5,061,516 |
|
- |
|
98 Records found
|
|
Page 3 of 4 |
|
|
0.05 (6.56%) 
